CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-12 | Zanganeh Mahkam Chief Executive Officer | Purchase | +5,000 | $2.07 | $10K | 494,814 |
| 2023-12-11 | Zanganeh Mahkam Chief Executive Officer | Option exercise | +489,814 | $1.44 | $705K | 489,814 |
| 2023-12-11 | Zanganeh Mahkam Chief Executive Officer | Option exercise | +315,681 | $1.58 | $499K | 24,889,479 |
| 2023-12-11 | Zanganeh Mahkam Chief Executive Officer | Option exercise · Warrant (right to buy) | −489,814 | 0 | ||
| 2023-12-11 | Zanganeh Mahkam Chief Executive Officer | Option exercise · Warrant (right to buy) | −315,681 | 0 | ||
| 2023-10-13 | Zanganeh Mahkam Chief Executive Officer | Grant or award · Stock Option (right to buy) | +11,988,198 | 11,988,198 | ||
| 2023-10-13 | Soni Manmeet Singh Chief Operating Officer | Purchase | +2,976,190 | $1.68 | $5.0M | 2,976,190 |
| 2023-10-13 | Soni Manmeet Singh Chief Operating Officer | Grant or award · Stock Option (right to buy) | +14,000,000 | 14,000,000 | ||
| 2023-03-08 | Zanganeh Mahkam Co-CEO & President | Purchase | +16,778,415 | $1.05 | $17.6M | 24,573,798 |
| 2023-03-08 | Zanganeh Mahkam Co-CEO & President | Purchase | +6,748,629 | $1.05 | $7.1M | 9,884,095 |
| 2023-03-08 | Zanganeh Mahkam Co-Chief Executive Officer | Purchase | +15,973,743 | $1.05 | $16.8M | 23,395,269 |
| 2023-03-08 | Zanganeh Mahkam Co-Chief Executive Officer | Purchase | +804,672 | $1.05 | $845K | 1,178,529 |
| 2023-03-08 | Zanganeh Mahkam Co-Chief Executive Officer | Purchase | +6,748,629 | $1.05 | $7.1M | 9,884,095 |
| 2023-03-07 | Dhingra Ankur Chief Financial Officer | Purchase | +196,362 | $1.05 | $206K | 234,558 |
| 2023-03-06 | DUGGAN ROBERT W Chief Executive Officer | Purchase | +376,489,880 | $1.05 | $395.3M | 552,354,161 |
| 2023-01-03 | Cesano Alessandra Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-03 | Cesano Alessandra Director | Grant or award · Stock Option (right to buy) | +16,350 | $1.67 | $27K | 51,350 |
| 2023-01-03 | Mahatme Ujwala Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-03 | Mahatme Ujwala Director | Grant or award · Stock Option (right to buy) | +40,500 | $1.67 | $68K | 75,500 |
| 2023-01-03 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 6 of 9 · 163 trades